Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States Bernstein, E., VanBuren, J., Assassi, S., Castelino, F., Chung, L., Correia, C., Evnin, L., Frech, T., Startup, E., Gordon, J., Hant, F., Hummers, L., Sandorfi, N., Shah, A., Shanmugam, V., Steen, V., Khanna, D. WILEY. 2021: 795-798
View details for Web of Science ID 000744545201144